Search results for " CARDIOVASCULAR"

showing 10 items of 6790 documents

Subclinical atherosclerosis: independent predictor of cardiovascular events in a 20-years follow up of patients with or without metabolic syndrome

2013

Purpose: To evaluate the influence of carotid atherosclerosis and metabolic syndrome (MetS) on the prediction of cardiovascular events during a 20-years follow-up. Methods: We studied a population of 529 asymptomatic patients, divided into 2 groups according to the results of the carotid ultrasound evaluation: one without atherosclerotic lesions (198 patients) and a second one with an increased carotid IMT or asymptomatic carotid plaque (331 patients). In each of these groups, we identified two subgroups of subjects with and without MetS. Cardiovascular endpoints were investigated in a 20-years follow-up: acute myocardial infarction, angina, transient ischemic attack, ischemic stroke, abdom…

medicine.medical_specialtyeducation.field_of_studybusiness.industrySurrogate endpointmedicine.medical_treatmentPopulationmedicine.diseaseAsymptomaticAbdominal aortic aneurysmAnginaAtherectomyInternal medicinemedicineCardiologyMyocardial infarctionmedicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinesseducationEuropean Heart Journal
researchProduct

Usefulness and limitations of contractile reserve evaluation in patients with low-flow, low-gradient aortic stenosis eligible for cardiac resynchroni…

2014

Aims In low-flow, low-gradient aortic stenosis (LF/LG AS), the assessment of contractile reserve (CR) by dobutamine stress echocardiography (DSE) is recommended for risk stratification and treatment strategy. However, DSE may show limitations in cases of left ventricular dyssynchrony (LVD). The impact of LVD in LF/LG AS, and the feasibility of CRT in this setting have never been evaluated. We aimed to assess: (i) the proportion of LF/LG AS patients with LVD; (ii) the influence of LVD on CR at DSE; and (iii) the effects of CRT in these patients. Methods and results Thirty consecutive patients with LF/LG AS underwent DSE with study of CR. The operative risk for aortic valve replacement (AVR) …

medicine.medical_specialtyeducation.field_of_studybusiness.industrymedicine.medical_treatmentPopulationCardiac resynchronization therapyEuroSCOREmedicine.diseaseAfterloadAortic valve replacementHeart failureInternal medicineAortic valve stenosiscardiovascular systemCardiologyMedicineCardiology and Cardiovascular MedicinebusinesseducationVentricular dyssynchronyEuropean Journal of Heart Failure
researchProduct

Primary Persistent Atrial Fibrillation: A Distinct Arrhythmia Subentity of an Ablation Population

2015

INTRODUCTION Persistent atrial fibrillation (persAF) can occur either as a sustained arrhythmia that has progressed from initially paroxysmal AF or as primary persAF without a history of any spontaneously terminated episode. There is a paucity of data differentiating between the 2 different persAF entities. Thus, we prospectively evaluated baseline characteristics, electrophysiological features, and ablation outcome in these 2 patient cohorts. METHODS AND RESULTS A total number of 154 consecutive persAF patients (63 ± 10 years, f = 42, longstanding persAF = 60) were characterized in terms of having primary persAF (P-persAF group) or persAF that secondarily progressed from paroxysmal AF (S-p…

medicine.medical_specialtyeducation.field_of_studybusiness.industrymedicine.medical_treatmentPopulationCatheter ablationAtrial fibrillationAblationmedicine.diseasePhysiology (medical)Heart failurePredictive value of testsInternal medicineCardiologyMedicineMedical historyCardiology and Cardiovascular MedicinebusinessProspective cohort studyeducationJournal of Cardiovascular Electrophysiology
researchProduct

ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION)

2021

Abstract Objectives This study sought to determine if percutaneous coronary intervention (PCI) prior to transcatheter aortic valve replacement (TAVR) in patients with significant coronary artery disease would produce noninferior clinical results when compared with no PCI (control arm). Background PCI in patients undergoing TAVR is not without risk, and there are no randomized data to inform clinical practice. Methods Patients with severe symptomatic aortic stenosis and significant coronary artery disease with Canadian Cardiovascular Society class ≤2 angina were randomly assigned to receive PCI or no PCI prior to TAVR. The primary endpoint was a composite of all-cause death or rehospitalizat…

medicine.medical_specialtyeducation.field_of_studybusiness.industrymedicine.medical_treatmentPopulationPercutaneous coronary interventionCanadian Cardiovascular Societymedicine.diseaseCoronary artery diseaseAnginasurgical procedures operativeValve replacementInternal medicineConventional PCImedicineCardiologycardiovascular diseasesMyocardial infarctionCardiology and Cardiovascular MedicineeducationbusinessJACC: Cardiovascular Interventions
researchProduct

Comparison of Sulfur Hexafluoride Microbubble (SonoVue)-Enhanced Myocardial Contrast Echocardiography With Gated Single-Photon Emission Computed Tomo…

2013

Objectives The purpose of this study was to compare sulfur hexafluoride microbubble (SonoVue)-enhanced myocardial contrast echocardiography (MCE) with single-photon emission computed tomography (SPECT) relative to coronary angiography (CA) for assessment of coronary artery disease (CAD). Background Small-scale studies have shown that myocardial perfusion assessed by SonoVue-enhanced MCE is a viable alternative to SPECT for CAD assessment. However, large multicenter studies are lacking. Methods Patients referred for myocardial ischemia testing at 34 centers underwent rest/vasodilator SonoVue-enhanced flash-replenishment MCE, standard Tc-99m-labeled electrocardiography-gated SPECT, and quanti…

medicine.medical_specialtyeducation.field_of_studymedicine.diagnostic_testSonoVuebusiness.industryPopulationischemiaSingle-photon emission computed tomographymedicine.diseasecontrast echocardiographyDipyridamoleCoronary artery diseaseStenosisInternal medicinemedicineStress EchocardiographyCardiologyCardiology and Cardiovascular MedicinebusinesseducationNuclear medicinePerfusionEmission computed tomographymedicine.drugJournal of the American College of Cardiology
researchProduct

Magnetic resonance in isolated noncompaction of the ventricular myocardium

2010

Abstract Non-compaction of the ventricular myocardium (LCVM) is a rare disorder of myocardial morphogenesis usually diagnosed in paediatric age. The diagnosis was echocardiographically made on the basis of a reported spongeous/compacted ratio >2 in one or more segments of the left ventricle during the diastolic period. We aimed to test the diagnostic accuracy of cardiovascular magnetic resonance (CMR) imaging in distinguishing pathological left ventricular non-compaction. Methods We collected a consecutive series of 8 patients, 5 males and 3 females, with a mean age of 14.9 years with non-compaction of left ventricular myocardium. All patients were admitted in our divisions of cardiology. I…

medicine.medical_specialtyeducation.field_of_studymedicine.diagnostic_testbusiness.industryPopulationDiastoleMagnetic resonance imagingResonance myocardiumSettore MED/11 - Malattie Dell'Apparato CardiovascolareApex (geometry)Ventricular myocardiummedicine.anatomical_structureVentricleNon-compaction of the ventricular myocardium (LCVM)Internal medicinecardiovascular systemLeft ventricular myocardiummedicineCardiologyCardiology and Cardiovascular MedicinebusinesseducationGradient echoCardiovascular magnetic resonance (CMR)
researchProduct

Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19

2020

Hospital admissions and mortality from the Coronavirus disease 2019 (COVID-19) pandemic are spreading throughout the world, and second and third waves are thought to be likely. Risk factors for severe COVID-19 include diabetes, chronic kidney disease and cardiovascular disease. Currently, there is no vaccine and no approved therapy. Therapeutic approaches are aimed at preventing viral replication and spread, limiting the impact of the inflammatory overdrive (cytokine storm), preventing thromboembolic complications and replacing or supporting organ function. However, despite organ support, mortality is currently 65% for those receiving advanced respiratory support and 78% for those requiring…

medicine.medical_specialtyempagliflozinEmpagliflozinlcsh:MedicineContext (language use)ReviewDisease030204 cardiovascular system & hematologyCardiovascularSGLT203 medical and health scienceschemistry.chemical_compound0302 clinical medicineChronic kidney diseaseDiabetes mellitusmedicine030212 general & internal medicineCanagliflozinDapagliflozincanagliflozinIntensive care medicinediabetesbusiness.industrycardiovascularDiabeteslcsh:RCOVID-19dapagliflozinGeneral MedicineDapagliflozinmedicine.diseaseVirusClinical trialRespiratory failurechemistryCytokine stormbusinesschronic kidney diseaseKidney diseaseJournal of Clinical Medicine
researchProduct

Insulin resistance and polycystic ovary syndrome.

2008

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in humans, affecting approximately 7-8% of women of reproductive age. Despite the criteria adopted, PCOS is considered to be a predominantly hyperandrogenetic syndrome and the evaluation of metabolic parameters and insulin sensitivity is not mandatory. Most women with PCOS also exhibit features of the metabolic syndrome, including insulin resistance, obesity and dyslipidaemia. While the association with type 2 diabetes is well established, whether the incidence of cardiovascular disease is increased in women with PCOS remains unclear. Acknowledging the strong impact of insulin-resistance in the genesis of PCOS co…

medicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Type 2 diabetesDiseaseEnvironmentBioinformaticsSettore MED/13 - EndocrinologiaInsulin resistanceRisk FactorsDiabetes mellitusInternal medicinemedicineHumansHypoglycemic AgentsGenetic Predisposition to DiseaseNutrition and Dieteticsbusiness.industryIncidenceHyperandrogenismnutritional and metabolic diseasesmedicine.diseasePolycystic ovaryObesityfemale genital diseases and pregnancy complicationsEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesFemaleInsulin resistance pcosMetabolic syndromeInsulin ResistanceCardiology and Cardiovascular MedicinebusinessPolycystic Ovary SyndromeNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Gestational diabetes and the metabolic syndrome: Can obesity and small, dense low density lipoproteins be key mediators of this association?

2013

Gestational diabetes mellitus (GDM) represents a condition of glucose intolerance with first appearance or recognition at the time of a pregnancy, associated with an inadequate pancreatic response to the advanced insulin resistance of the later stages of pregnancy, and accompanied by enhancing β-cell mass and secretion of insulin. Women who had GDM exhibit a higher risk for later advent of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD). Additionally, previous GDM has been proposed as independently correlated with higher risk for development of atherosclerosis in a healthy population, similar to the metabolic syndrome (MetS) and independently of the presence of established…

medicine.medical_specialtyendocrine system diseasesPharmaceutical ScienceInsulin resistancePregnancyDiabetes mellitusInternal medicineHumansMedicineObesityMetabolic SyndromePregnancybusiness.industryObstetricsnutritional and metabolic diseasesType 2 Diabetes Mellitusmedicine.diseaseObesityLipoproteins LDLGestational diabetesDiabetes GestationalEndocrinologyFemaleMetabolic syndromecardiovascular disease cardiovascular risk gestational diabetes mellitus metabolic syndrome small dense low-density lipoprotein type 2 diabetes mellitusbusinessPostpartum periodBiotechnology
researchProduct

The importance of diagnosing the Polycystic Ovary Syndrome

2000

The polycystic ovary syndrome (PCOS) is an extremely common disorder that occurs in 4% to 7% of women of reproductive age. Although PCOS is known to be associated with reproductive morbidity and increased risk for endometrial cancer, diagnosis is especially important because PCOS is now thought to increase metabolic and cardiovascular risks. These risks are strongly linked to insulin resistance and are compounded by the common occurrence of obesity, although insulin resistance and its associated risks are also present in nonobese women with PCOS. Women with PCOS are at increased risk for impaired glucose tolerance, type 2 diabetes mellitus, and hypertension. Cardiovascular disease is believ…

medicine.medical_specialtyendocrine system diseasesPhysiologyType 2 diabetesImpaired glucose toleranceInsulin resistanceDiabetes mellitusInternal medicineGlucose IntoleranceInternal MedicinemedicineHumansRisk factorbusiness.industryFibrinolysisnutritional and metabolic diseasesType 2 Diabetes MellitusGeneral Medicinemedicine.diseaseObesityPolycystic ovaryLipidsfemale genital diseases and pregnancy complicationsEndocrinologyCardiovascular DiseasesFemalepolycystic ovary syndrome cardiovascular risk insuline resistanceInsulin ResistancebusinessHyperandrogenismAnovulationPolycystic Ovary Syndrome
researchProduct